Press Releases
 
Research Delivers Insight into the Global Outlook for Erdosteine Market

Erdosteine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

, 11 August 2017 -- Transparency Market Research Report Added "Erdosteine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024"

Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and enhances elimination. Erdosteine shows inhibitory activity against the effects of free radicals produced by cigarette smoke.

Pharmacokinetically, it acts by absorption, distribution, metabolism, and excretion. The elimination half-life of Erdosteine is about 1.46 hr. Adverse events of Erdosteine are quite low, and generally mild. It has been clinically proven that Erdosteine has good gastric tolerability after oral administration, and does not cause reflux phenomena like other thiols derivatives. Erdosteine has no direct effect on gastric mucus.

Increasing prevalence of respiratory diseases, rising geriatric population, rapid population growth, and environmental pollution due to industrialization are expected to fuel the global erdosteine market. According to the WHO, chronic obstructive pulmonary disease (COPD) accounts for three million deaths globally each year and the number is expected to increase in the next few years. About 90% of chronic obstructive pulmonary disease (COPD) deaths occur in developing and underdeveloped countries.

Rising research and development activities, increasing health care insurance coverage, and growing adoption for treatment options are the other factors driving the global erdosteine market. On the other hand, stringent regulations for product approval are likely to hamper the growth of the global erdosteine market. Erdosteine is used for rare diseases so maximum companies doing research and development which will increase the market competitiveness. Erdosteine is marketed in over 40 countries for the treatment of various respiratory diseases.

The erdosteine market has been segmented based on dosage form, age group, application, distribution channel, and region. In terms of dosage form, the market has been classified into capsules, dry suspension, dispersible tablets, and sachets. The capsule dosage form is highly used due to ease of use, availability in unit dosage form, and also easy in term of prescription scenario which will leads to less side effect. Based on age group, the erdosteine market has been segmented into ##### and pediatric.

In terms of application, the market has been classified into chronic obstructive pulmonary disease (COPD), acute bronchitis (AB), and chronic bronchitis (CB). Based on distribution channel, the erdosteine market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
In terms of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Fill the Form for an Exclusive Sample of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19166

North America dominated the erdosteine market due to rising geriatric population, early adoption of treatment procedures, and increasing prevalence of respiratory diseases. The geriatric population represents about 14.5% of the population of the U.S. According to the U.S. Department of Health and Human Service, the geriatric population will increase to 98 million by 2060, which is twice that in 2014. Europe is the second largest market for erdosteine attributed to increasing research and development activities and rising number of commercial licensing partnerships for erdosteine manufacturing. Asia Pacific is expected to grow at a higher rate driven by growing per capita expenditure, increasing health care insurance coverage, rapidly growing population, and rising per capita health care expenditure.

Major players operating in the erdosteine market include Edmond Pharma S.R.L., Alitair Pharmaceuticals, Manus Aktteva Biopharma LLP, Enaltec, Reine Life Science, Taj Pharmaceuticals Ltd., Recipharm AB, Glenmark Pharmaceuticals Ltd., Sigma-Aldrich Co. LLC, Genome Pharmaceuticals (Pvt.) Ltd., and Milan Pharma.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 11 August 2017 at 5:56 PM
Category: Health Care & Medical
 
Related News

Prescription Doctor - Portal operator allowing access to regulated UK online doctor and pharmacy ser
Tuesday, 23 Jan 2018

Idiopathic Short Stature Market Latest Trends and Forecast Analysis Upto 2020
Tuesday, 23 Jan 2018

Healthcare Facilities Management Market to Become Worth US$577.92 bn by 2025
Tuesday, 23 Jan 2018

Multiple Reaction Monitoring Assay Market to Develop Rapidly by 2024
Tuesday, 23 Jan 2018

High Throughput Process Development Market to Become Worth US$ 18.3 bn by 2022
Tuesday, 23 Jan 2018

Related Events

Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
Monday, 22 Jan 2018

Cell & Gene Therapy World
Monday, 22 Jan 2018

Immuno-Oncology Frontiers World
Monday, 22 Jan 2018

Patients as Partners Europe
Tuesday, 23 Jan 2018

Hyphenated Techniques in Chromatography Cardiff January 2018
Wednesday, 24 Jan 2018

Latest News

Things to consider prior to buy injection molds
Tuesday, 23 Jan 2018

Alkylated Naphthalene Sulfonate Market Overview | Forecast & Analysis (2016-2020)
Tuesday, 23 Jan 2018

Global Baby Care Product Market - By End User, Vendors and Geography Market Shares, Forecasts and Tr
Tuesday, 23 Jan 2018

ExpressVPN Update Supports Android TV and Amazon Fire TV
Tuesday, 23 Jan 2018

Make Passive AdSense Earnings via Android Apps from AdSense Gorilla
Tuesday, 23 Jan 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 January 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
  • Advancing Construction Claims 2018 Conference Atlanta, GA
  • Cell & Gene Therapy World
  • Immuno-Oncology Frontiers World
  • Patients as Partners Europe

  • Latest Jobs
    Sorry, there are currently no entries posted here.